Allarity Therapeutics, Inc.
ALLR
$1.15
$0.065.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 18.49% | -106.98% | -88.86% | -105.99% | -44.30% |
| Total Depreciation and Amortization | -217.65% | 38.10% | -37.93% | -75.68% | -43.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -72.69% | 306.23% | 292.23% | 278.05% | 381.23% |
| Change in Net Operating Assets | 40.94% | -438.29% | -160.32% | -111.43% | -200.75% |
| Cash from Operations | 6.54% | -6.76% | -70.33% | -36.15% | -17.01% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -100.00% | -100.00% | 27.62% | -34.63% |
| Total Debt Repaid | 100.00% | 100.00% | 63.77% | 63.77% | 63.74% |
| Issuance of Common Stock | -47.00% | -48.00% | 152.67% | 95.18% | 80.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | -- | -- | 153.28% | 153.28% |
| Repurchase of Preferred Stock | 100.00% | 30.00% | 47.38% | 47.40% | 47.40% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.28% | -48.99% | 315.04% | 234.62% | 188.32% |
| Foreign Exchange rate Adjustments | -717.26% | -1,960.82% | 12.06% | 299.12% | 59.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -109.19% | -107.61% | 161,029.41% | 1,139.56% | 769.96% |